EquityBulls

Latest News

Keywords Selected: Therapeutics

Stock Report

Glenmark Therapeutics Inc., USA launches Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful - OTC
Sun Pharma to acquire Checkpoint Therapeutics
Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% OTC
Shilpa's CDMO customer reported positive results from pivotal clinical trial & placed binding purchase order
NATCO Pharma Limited invests around US$ 2 million in Cellogen Therapeutics Private Limited
Dr. Reddy's Laboratories, Inc. acquires Preferred A-1 shares of Edity Therapeutics Ltd
Dr. Reddy's Laboratories SA enters into agreement for COYA 302
Sentynl Therapeutics Completes Asset Transfer of CUTX-101 from Cyprium Therapeutics
Sun Pharmaceutical Industries, Inc. inks icensing agreement with Aclaris Therapeutics, Inc
Kotak Alternate Asset Managers Ltd acquires CCPS of NKURE Therapeutics Pvt TLd
Ichnos Sciences Enters Licensing Agreement For OX40 Antagonist Monoclonal Antibody Portfolio with Astria Therapeutics
Lupin Launches Authorized Generic Version of PENNSAID® 2% w/w in the United States
BridgeBio Pharma and Sentynl Therapeutics Receive Marketing Authorization in the EU for NULIBRY® (fosdenopterin) for the Treatment of MoCD Type A
Dr. Reddy's Laboratories announces conclusion of patent litigation with Indivior Inc
Dr. Reddy's Laboratories Limited enters into settlement agreement with Indivior Inc
Sentynl Therapeutics and BridgeBio Pharma announce asset purchase agreement
Shilpa Biologicals partners with Mylab
Fortress Biotech and Cyprium Therapeutics Announce Positive Clinical Data for CUTX-101, Copper Histidinate

Industry News

Wundrsight raises USD 400K in a Seed Round led by Inflection Point Ventures